Ian Gilham, an industry veteran, has been appointed non-executive director of Horizon Discovery Ltd, a provider of research tools for the development of personalised medicine. Dr Gilham is currently non-executive chairman of Multiplicom NV, which develops DNA sequencing products, and Biosurfit SA, which develops point-of-care diagnostics. He has previously been chief executive of Axis-Shield Plc and vice president, pharmacogenetics and diagnostics, at GlaxoSmithKline Plc.
Horizon announced the appointment on 1 August 2013.
Copyright 2013 Evernow Publishing Ltd